Recent Finacing
Recent Raise
Kriya Therapeutics develops and manufactures AAV-based gene therapies using computational vector design (SIRVE™) and in-house GMP manufacturing (STRIPE™), advancing programs in ophthalmology, metabolic disease, neurology, and oncology.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
